Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Apr 2, 2009
Distillery Therapeutics
Indication: Various
...in JNK3-deficient mice and testing JNK3 inhibitors for their antiangiogenic effects. An SDF-1 antibody from
RegenMed Corp.
...
Read More
BioCentury
|
Feb 20, 2006
Clinical News
RegenMed preclinical data
...retinal architecture leading to vision problems. Data were presented at the Angiogenesis meeting in Miami.
RegenMed Corp.
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Apr 2, 2009
Distillery Therapeutics
Indication: Various
...in JNK3-deficient mice and testing JNK3 inhibitors for their antiangiogenic effects. An SDF-1 antibody from
RegenMed Corp.
...
Read More
BioCentury
|
Feb 20, 2006
Clinical News
RegenMed preclinical data
...retinal architecture leading to vision problems. Data were presented at the Angiogenesis meeting in Miami.
RegenMed Corp.
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page